- Home
- SDHC vs ANIK Comparison
SDHC vs ANIK Comparison
Compare SDHC & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDHC | ANIK |
|---|---|---|
| Founded | 2008 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.0M | 153.3M |
| IPO Year | 2023 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SDHC | ANIK |
|---|---|---|
| Price | $15.83 | $14.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $16.70 | $16.00 |
| AVG Volume (30 Days) | 54.3K | ★ 143.4K |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.09 |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $975,463,000.00 | $119,907,000.00 |
| Revenue This Year | $0.58 | $5.20 |
| Revenue Next Year | $6.61 | $4.69 |
| P/E Ratio | $20.32 | ★ N/A |
| Revenue Growth | ★ 27.57 | N/A |
| 52 Week Low | $15.00 | $7.90 |
| 52 Week High | $23.50 | $17.61 |
Technical Indicators
Market Signals| Indicator | SDHC | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 31.74 | 87.62 |
| Support Level | N/A | $9.36 |
| Resistance Level | $21.44 | $15.10 |
| Average True Range (ATR) | 0.92 | 0.57 |
| MACD | -0.22 | 0.32 |
| Stochastic Oscillator | 4.96 | 91.49 |
Price Performance
Historical ComparisonAbout SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.